Synthesis-to-Clinic®: integrating isotopic labeling and human ADME to reduce time to clinic
Pharmaceutical Technology
NOVEMBER 24, 2022
We asked them to explain how the company has integrated its isotopic labeling and human ADME testing services to help streamline the drug development process and accelerate the time it takes to get drugs to market. How are human ADME studies designed? How does your unique Synthesis-to-Clinic® offering streamline the drug development process?
Let's personalize your content